Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-ELI411 PET Imaging in Solid Tumors
NCT07741006Phase 1Enrolling by invitation
- Start
- Jun 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [68Ga]Ga-ELI411 in malignant solid tumor. Primary endpoint: Semiquantitative SUV Parameters of Lesions on [68Ga]Ga-ELI411 PET at 7 days. Started Jun 2026; status: enrolling by invitation.
02
Drugs
[68Ga]Ga-ELI411
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT07741006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07741006.